Search | VHL Search Portal

1.

How do the Institute for Clinical and Economic Review's Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee's Assessments of Added Benefit? A Qualitative Study.

DiStefano, Michael J; Pearson, Steven D; Rind, David M; Zemplenyi, Antal.

Value Health ; 2024 Apr 26.

Article in English | MEDLINE | ID: mdl-38679288

2.

The ethical canary: narrow reflective equilibrium as a source of moral justification in healthcare priority-setting.

Charlton, Victoria; DiStefano, Michael J.

J Med Ethics ; 2024 Feb 19.

Article in English | MEDLINE | ID: mdl-38373831

3.

Estimated Savings From Using Added Therapeutic Benefit and Therapeutic Reference Pricing in United States Medicare Drug Price Negotiations.

DiStefano, Michael J; Levy, Joseph F; Odouard, Ilina C; Anderson, Gerard F.

Value Health ; 26(11): 1618-1624, 2023 11.

Article in English | MEDLINE | ID: mdl-37689264

4.

Incorporating Added Therapeutic Benefit and Domestic Reference Pricing Into Medicare Payment for Expensive Part B Drugs.

Anderson, Kelly E; DiStefano, Michael J; Liu, Angela; Mattingly, T Joseph; Socal, Mariana P; Anderson, Gerard F.

Value Health ; 26(9): 1381-1388, 2023 09.

Article in English | MEDLINE | ID: mdl-37285915

5.

Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising.

DiStefano, Michael J; Markell, Jenny M; Doherty, Caroline C; Alexander, G Caleb; Anderson, Gerard F.

JAMA ; 329(5): 386-392, 2023 02 07.

Article in English | MEDLINE | ID: mdl-36749334

6.

Developing and piloting a context-specified ethics framework for health technology assessment: the South African Values and Ethics for Universal Health Coverage approach.

Krubiner, Carleigh B; Barsdorf, Nicola W; Goldstein, Susan J; Mosam, Atiya; Potgieter, Sunita; DiStefano, Michael J; Tugendhaft, Aviva; Merritt, Maria W; Li, Ryan; Chalkidou, Kalipso; Faden, Ruth R; Hofman, Karen J.

Int J Technol Assess Health Care ; 38(1): e26, 2022 Mar 08.

Article in English | MEDLINE | ID: mdl-35256036

7.

Assessing the Added Therapeutic Benefit of Ultra-Expensive Drugs.

DiStefano, Michael J; Kang, So-Yeon; Yehia, Farah; Morales, Christian; Anderson, Gerard F.

Value Health ; 24(3): 397-403, 2021 03.

Article in English | MEDLINE | ID: mdl-33641774

8.

Comparative Approaches to Drug Pricing.

Kang, So-Yeon; Bai, Ge; DiStefano, Michael J; Socal, Mariana P; Yehia, Farah; Anderson, Gerard F.

Annu Rev Public Health ; 41: 499-512, 2020 04 02.

Article in English | MEDLINE | ID: mdl-31874070

9.

Beyond the numbers: a critique of quantitative multi-criteria decision analysis.

DiStefano, Michael J; Krubiner, Carleigh B.

Int J Technol Assess Health Care ; : 1-5, 2020 Jul 01.

Article in English | MEDLINE | ID: mdl-32605684

10.

Promoting Justice in Locating and Tracking Research Participants Through Social Media.

DiStefano, Michael J; Rivera, Yonaira M; Thrul, Johannes; Ali, Joseph.

Am J Bioeth ; 19(6): 71-73, 2019 06.

Article in English | MEDLINE | ID: mdl-31135312

11.

Assessing clinical benefit in the Medicare Drug Price Negotiation Program: A 2-step approach for improving transparency, consistency, and meaningful patient engagement.

DiStefano, Michael J; Zemplenyi, Antal; McQueen, R Brett.

J Manag Care Spec Pharm ; 30(3): 252-258, 2024 Mar 01.

Article in English | MEDLINE | ID: mdl-38241282

12.

Alternative approaches to measuring value: an update on innovative methods in the context of the United States Medicare drug price negotiation program.

DiStefano, Michael J; Zemplenyi, Antal; Anderson, Kelly E; Mendola, Nicholas D; Nair, Kavita V; McQueen, Robert Brett.

Expert Rev Pharmacoecon Outcomes Res ; 24(2): 171-180, 2024 Feb.

Article in English | MEDLINE | ID: mdl-37961908

13.

Using Real-World Data to Inform Value-Based Contracts for Cell and Gene Therapies in Medicaid.

Zemplenyi, Antal; Leonard, Jim; DiStefano, Michael J; Anderson, Kelly E; Wright, Garth C; Mendola, Nicholas D; Nair, Kavita; McQueen, R Brett.

Pharmacoeconomics ; 42(3): 319-328, 2024 Mar.

Article in English | MEDLINE | ID: mdl-37989969

14.

Characterizing "Civil Unrest" as a Public Health Determinant.

DiStefano, Michael J.

Am J Public Health ; 108(7): e20, 2018 07.

Article in English | MEDLINE | ID: mdl-29874496

15.

Comparison of integrated and isolated training on performance measures and neuromuscular control.

Distefano, Lindsay J; Distefano, Michael J; Frank, Barnett S; Clark, Micheal A; Padua, Darin A.

J Strength Cond Res ; 27(4): 1083-90, 2013 Apr.

Article in English | MEDLINE | ID: mdl-23364296

16.

Moral and Social Values in Evidence-Informed Deliberative Processes for Health Benefit Package Design Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".

DiStefano, Michael J.

Int J Health Policy Manag ; 12: 7480, 2023.

Article in English | MEDLINE | ID: mdl-37579447

17.

Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.

DiStefano, Michael J; Kang, So-Yeon; Parasrampuria, Sonal; Anderson, Gerard F.

JAMA Health Forum ; 4(5): e231090, 2023 05 05.

Article in English | MEDLINE | ID: mdl-37234016

18.

Integrating Health Technology Assessment and the Right to Health in South Africa: A Qualitative Content Analysis of Substantive Values in Landmark Judicial Decisions.

DiStefano, Michael J; Karim, Safura Abdool; Krubiner, Carleigh B; Hofman, Karen J.

J Law Med Ethics ; 51(1): 131-149, 2023.

Article in English | MEDLINE | ID: mdl-37226744

19.

The Value of Explicit, Deliberative, and Context-Specified Ethics Analysis for Health Technology Assessment: Evidence From a Novel Approach Piloted in South Africa.

Krubiner, Carleigh B; Tugendhaft, Aviva; DiStefano, Michael J; Barsdorf, Nicola W; Merritt, Maria W; Goldstein, Susan J; Mosam, Atiya; Potgieter, Sunita; Hofman, Karen J; Faden, Ruth R.

Value Health Reg Issues ; 34: 23-30, 2023 Mar.

Article in English | MEDLINE | ID: mdl-36455448

20.

Wearable Biometric Technologies and Public Health.

DiStefano, Michael J.

Am J Bioeth ; 17(1): 79-81, 2017 01.

Article in English | MEDLINE | ID: mdl-27996903

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export:

How do the Institute for Clinical and Economic Review's Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee's Assessments of Added Benefit? A Qualitative Study.

The ethical canary: narrow reflective equilibrium as a source of moral justification in healthcare priority-setting.

Estimated Savings From Using Added Therapeutic Benefit and Therapeutic Reference Pricing in United States Medicare Drug Price Negotiations.

Incorporating Added Therapeutic Benefit and Domestic Reference Pricing Into Medicare Payment for Expensive Part B Drugs.

Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising.

Developing and piloting a context-specified ethics framework for health technology assessment: the South African Values and Ethics for Universal Health Coverage approach.

Assessing the Added Therapeutic Benefit of Ultra-Expensive Drugs.

Comparative Approaches to Drug Pricing.

Beyond the numbers: a critique of quantitative multi-criteria decision analysis.

Promoting Justice in Locating and Tracking Research Participants Through Social Media.

Assessing clinical benefit in the Medicare Drug Price Negotiation Program: A 2-step approach for improving transparency, consistency, and meaningful patient engagement.

Alternative approaches to measuring value: an update on innovative methods in the context of the United States Medicare drug price negotiation program.

Using Real-World Data to Inform Value-Based Contracts for Cell and Gene Therapies in Medicaid.

Characterizing "Civil Unrest" as a Public Health Determinant.

Comparison of integrated and isolated training on performance measures and neuromuscular control.

Moral and Social Values in Evidence-Informed Deliberative Processes for Health Benefit Package Design Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".

Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.

Integrating Health Technology Assessment and the Right to Health in South Africa: A Qualitative Content Analysis of Substantive Values in Landmark Judicial Decisions.

The Value of Explicit, Deliberative, and Context-Specified Ethics Analysis for Health Technology Assessment: Evidence From a Novel Approach Piloted in South Africa.

Wearable Biometric Technologies and Public Health.